CLINICAL STUDIES
Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging 1
Jens Bremerich, MDa,
Michael F. Wendland, PhDa,
H.åkan Arheden, MD, PhDa,
Rolf Wyttenbach, MDa,
Dong W. Gao, MDa,
John P. Huberty, BSa,
Michael W. Dae, MDa,
Charles B. Higgins, MD, FACCa and
Maythem Saeed, DVM, PhDa
a Department of Radiology, University of California San Francisco, San Francisco, California, USA
Manuscript received February 4, 1998;
revised manuscript received May 11, 1998,
accepted May 20, 1998.
Address for correspondence: Dr. Charles B. Higgins, Department of Radiology, MRI-Section, University of California San Francisco, 505 Parnassus Avenue, L308, San Francisco, California 94143-0628 Charles.Higgins{at}radiology.ucsf.edu
 |
Abstract
|
|---|
Objectives. The purpose of this study was to measure the accumulation of labeled albumin and to visualize its distribution pattern in reperfused infarcted myocardium as a function of time between onset of reperfusion and administration of the tracer.
Background. Myocardial microvascular injury leads to leakage of albumin from the intravascular space. Quantitative measurements of GdDTPA-albumin with inversion recovery echoplanar imaging (IR-EPI) may allow noninvasive monitoring of microvascular injury.
Methods. After 1 h of coronary artery occlusion, 56 rats were injected with GdDTPA-albumin or 123I-GdDTPA-albumin either immediately before reperfusion or , 1 or 24 h after reperfusion. GdDTPA-albumin in blood, normal myocardium and reperfused infarction was dynamically measured with IR-EPI during 1 h postinjection (PI). Autoradiograms were obtained at 15 min PI. Accumulation of labeled albumin in myocardium was expressed as the ratio of myocardial to blood content.
Results. In normal myocardium, the ratio of changes of relaxation rate-ratio ( R1-ratio) was 0.12 ± 0.01 and did not change over 1 h. In reperfused infarction, however, the R1-ratio increased after administration. Animals given GdDTPA-albumin before reperfusion exhibited fastest accumulation ( R1-ratio 15 min PI: 0.56 ± 0.03) and essentially homogeneous distribution. The accumulation was slower when administered at , 1 and 24 h after reperfusion ( R1-ratios 15 min PI: 0.39 ± 0.03; 0.31 ± 0.04; 0.16 ± 0.01; p < 0.001 compared to administration before reperfusion). Moreover, the tracer accumulated predominantly in the periphery of the injury zone.
Conclusions. Amount and distribution pattern of labeled albumin in reperfused infarction are modulated by duration of reperfusion. The accumulation of GdDTPA-albumin can be quantified by IR-EPI. Thus, IR-EPI may be useful to noninvasively monitor myocardial microvascular injury in reperfused infarction.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | IR-EPI | = inversion recovery echoplanar imaging | | MRI | = magnetic resonance imaging | | R1 and T1 | = longitudinal relaxation rate and time | | TI | = inversion time | | TInull | = inversion time with nil signal arising from tissue | | TR and TE | = repetition and echo times | | TTC | = triphenyltetrazolium chloride |
|
Myocardial ischemia causes injury to myocytes and to the vasculature which supports myocardial perfusion. It is known that myocyte necrosis precedes damage to the microvasculature, as defined on histology (1). However, injury to the microvasculature as defined by leakage of plasma macromolecules can be observed even after mild ischemic insult (2,3). Moreover, this elevated permeability or microvascular injury seems to progress during reperfusion (4). A noninvasive method to monitor microvascular injury may be useful in evaluating myocardial injury.
Microvascular integrity has been studied in vivo with magnetic resonance imaging (MRI) using macromolecular gadolinium chelates like GdDTPA-albumin or GdDTPA-polylysine (57). Macromolecules such as GdDTPA-albumin are retained in the vasculature in normal myocardium, but leak into the interstitium in reperfused infarction; this causes a relatively increased quantity of GdDTPA-albumin within the injured region (6). On conventional T1-weighted MR images, the signal intensity in the abnormal region is increased (5,8,9), but since increased signal intensity on conventional MRI is not proportional to changes of GdDTPA-albumin concentration, quantification is complicated (10). However, a proportional relationship exists between changes in longitudinal relaxivity ( R1) and changes of GdDTPA-albumin concentration in the injury zone. Thus, direct R1 measurements with inversion recovery echoplanar imaging (IR-EPI) may provide quantification of GdDTPA-albumin accumulation in reperfused infarcted myocardium (11,12).
The distribution pattern of GdDTPA-albumin in reperfused infarcted myocardium is not always uniform (57). An increased tracer accumulation or hyperenhancement of the periphery of the infarct zone and a hypoenhancement of the infarct core have been demonstrated (3,5,6). This pattern of differential enhancement was more pronounced when the duration of ischemia increased (7). However, the direct effect of duration of reperfusion on the amount of GdDTPA-albumin in reperfused infarction is unclear. The accumulation of GdDTPA-albumin as a function of delay time between onset of reperfusion and tracer administration has not been studied.
Therefore, the specific aims of this study were to 1) validate the use of IR-EPI and R1 assessment for quantitative evaluation of microvascular dysfunction by comparison with a radionuclide based approach as the gold standard and 2) define the time course of pathophysiologic changes in myocardial microvasculature and regional blood volume early after reperfusion.
 |
Methods
|
|---|
Materials.
GdDTPA-albumin, a blood pool MRI contrast agent, was prepared by the method of Ogan et al. (13), in which the chelate DTPA was covalently linked to human serum albumin residues. This preparation yields GdDTPA-albumin with a molecular weight of approximately 92 kDa and T1, T2 relaxivities of 13.7, 18.4 mM1s1, respectively. This agent has been well characterized as an intravascular blood pool agent for MR imaging, with a plasma half-life of approximately 90 min (8). In normal myocardium this material is confined to the intravascular volume.
123I-GdDTPA-albumin was prepared by adding 123iodine (Cyclotron, Vancouver, Canada) to GdDTPA-albumin taken from the same stock solution as was used for contrast-enhanced MRI animals. The labeled product was purified by placing it over an AG-1X8 anion exchange column.
Animal preparation.
Care and maintenance of experimental animals were in strict accordance with the National Institutes of Health guidelines. The experimental protocol received prior approval from the Committee on Animal Research at this Institution. Female SpragueDawley rats (n = 56; 240 to 310 g; Simonsen Labs Inc., Gilroy, CA) were divided into four groups (n = 14 per group) for preparation of myocardial infarction with varied reflow duration (Fig. 1). Animals were prepared as described previously (6). Briefly, animals were anesthetized with sodium pentobarbital (50 mg/kg; IP). Catheters were placed in a jugular vein for administration of contrast agent or radiotracer and in a carotid artery for measurement of blood pressure (Gould Transducer, Gould Inc., Cleveland, OH) and withdrawal of blood. The chest was opened and the anterior branch of the left coronary artery was occluded for 1 h followed by reperfusion. This rat model of 1 h ischemia followed by reperfusion is known to produce substantial myocardial infarction and microvascular injury (6,14). GdDTPA-albumin (n = 8) or radiotracer (n = 6) was administered 3 min before reperfusion, at h, or 1 h after reperfusion for groups 1 to 3, respectively. Animals in group 4 were anesthetized with short-acting anesthesia (8 mg/100 g xylazine and 0.2 mg/100 g ketamine; IP). Surgical preparation and coronary occlusion duration were identical to groups 1 to 3. Reperfusion was maintained for 24 h. A total of 87 rats were prepared in the present study. Thirty-one rats died after occlusion (15) or reperfusion (13), but before administration of the contrast agent. No subjects were lost during the measurements. All completed experiments were included in the analysis.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1 Graph showing the four study groups. GdDTPA-albumin (n = 8 in each group) or 123I-GdDTPA-albumin (n = 6 in each group) were injected before reperfusion (group 1); after h (group 2); after 1 h (group 3); after 24 h of reperfusion (group 4). Magnetic resonance imaging in each group was performed over a 1-h period, or hearts were excised 15 min after injection and autoradiography performed. Solid bar = time of coronary artery occlusion (1 h); hatched bar = time during reperfusion at which GdDTPA-albumin or 123I-GdDTPA-albumin were injected and MRI or autoradiography was performed.
|
|
MRI experiments.
Magnetic resonance imaging was conducted on a Bruker Omega CSI 2 Tesla system (Bruker Instruments Inc., Fremont, CA) as previously described (16). Each animal was placed supine in a home-built bird cage resonator; the electrocardiogram signal was obtained from two subcutaneous copper needles. The field of view contained a phantom with known T1.
IR-EPI was conducted in the transverse plane to repeatedly measure T1 of left ventricular chamber blood, normally perfused myocardium and reperfused infarction. EPI sequence parameters were: matrix 64 x 64 points; field of view 50 x 50 mm; slice thickness 2 mm; acquisition time = 32.7 ms; echo time (TE) = 10 ms; pulse delay repetition time minus inversion time (TR-T1) > 4 x T1 (fully relaxed).
In each rat, 10 sets of 20 images each with different TI were acquired before and at 4, 9, 14, 19, 24, 29, 39, 49 and 59 min after administration of GdDTPA-albumin (0.03 mmol Gd/kg). These image sets were used to measure regional T1 values and calculate R1 as described previously (16). At the conclusion of T1 measurements, a conventional T1-weighted spin-echo image (TR 300 ms; TE = 25 ms; raw data matrix 256 x 128 zero filled to 256 x 256) was acquired at the same midventricular level.
After MR measurements, hearts were excised, rinsed, sliced at the midventricular level and stained by soaking in a 2% solution of triphenyltetrazolium chloride (TTC) at 37°C for 8 min to define the infarction. This staining procedure provides brick-red coloration of normal myocardium, whereas infarcted myocardium is unstained (14).
Radioisotope experiments.
Six rats per group were examined for distribution of 123I-GdDTPA-albumin (500 µCi). The tracer was allowed to circulate for 15 min since MRI data demonstrated maximal differences of R1-ratios among groups at that time. A sample of blood (0.5 ml) was then withdrawn from the carotid artery for radioactivity measurements. The coronary artery was reoccluded and phthalocyanine blue dye (particle size of 7.4 ± 3.2 µm) was administered intravenously to define the area at risk (17). The heart was excised and sliced at the midventricular level. Samples from both the unstained area at risk and the blue-stained, normally perfused myocardium were taken from the apical portion of the transsected heart. Samples were weighed and radioactivity counted in a gamma-counter was measured (Searle-Analytic Inc., Tampa, Florida). The basal portion of the transsected heart was placed in embedding medium (Tissue-Tek, Sakura Finetechnical Co. LTD, Tokyo), immediately frozen in dry ice and sectioned (20 µm). Sections were placed on a photostimulable storage phosphor imaging plate (Molecular Dynamics, Sunnyvale, CA) to obtain digital autoradiograms. These were evaluated using software (ImageQuant, Molecular Dynamics, Sunnyvale, CA) to determine the distribution of radioactivity in these slices.
MRI data analysis.
The inversion time with nil signal (TInull) was determined for normally perfused myocardium, reperfused infarcted myocardium, ventricular blood and phantom using an image analysis program (NIH-image). T1 values and R1-ratios were calculated as described previously (16):
 | (1) |
 | (2) |
R1-ratios were plotted vs. time. Regional blood volume was estimated by fitting the R1-ratios of reperfused infarcted and of normal myocardium and by extrapolating the fitted curves to the time of GdDTPA-albumin injection. Myocardial blood volumes of the infarcted regions were expressed as a percentage of normal myocardium.
Radioisotope data analysis.
The radioactivity ratio of normally perfused myocardium was calculated as:
 | (3) |
The injury zone was defined by a count density of 2 SD higher than the mean of normally perfused myocardium. The radioactivity ratio of injured myocardium was calculated as:
 | (4) |
The same slices were scanned with a flatbed scanner (Epson, Seiko Epson Corp., Japan); data were processed on a Macintosh computer with image analysis software (NIH-image). The area at risk defined as unstained tissue was measured and expressed as a percentage of the total cross-sectional area of the left ventricular slice.
Statistical analysis.
All values are expressed as mean ± SEM. Comparisons among groups at 15 min after contrast administration were made with a one-way analysis of variance (ANOVA). If the analysis showed an overall p < 0.05 value, Scheffés test was implemented as post hoc test. For single comparisons a paired Students t test was used. A p value of <0.05 was considered significant.
 |
Results
|
|---|
Hemodynamic data.
Administration of 123I-GdDTPA-albumin caused no significant changes in heart rate (309 ± 12 vs. 298 ± 12 beats/min) or in systolic (112 ± 6; 120 ± 5 mm Hg), diastolic (87 ± 5; 92 ± 5 mm Hg) or mean (98 ± 6; 105 ± 5 mm Hg) blood pressures. Heart rate and blood pressure did not differ among the groups.
MRI data.
Precontrast T1 of infarction (1.13 ± 0.03 s) was longer than that of normal myocardium (0.92 ± 0.02 s) (p < 0.05; Students paired t test). After GdDTPA-albumin administration, T1 of blood, reperfused infarction and normal myocardium decreased by ninefold, twofold to fourfold and twofold, respectively. However, regional variation of T1 shortening occurred, which reflects regional variations of GdDTPA-albumin content. Representative IR-EPI images obtained at identical anatomical level but with different TI settings demonstrate regional differences in GdDTPA-albumin content (Fig. 2). The shortest TInull was found in the blood pool, indicating greatest concentration of GdDTPA-albumin. The TInull of reperfused infarction decreased steadily with time after injection of GdDTPA-albumin, reflecting accumulation of the tracer.

View larger version (143K):
[in this window]
[in a new window]
|
Figure 2 Axial IR-EPI of a rat heart acquired at the same anatomical level but with different TI settings. After 1 h coronary occlusion and 24 h reperfusion, GdDTPA-albumin was administered; IR-EPI were acquired 4 min later. A strong negative signal was observed for blood and the entire myocardium with TI = 20 ms (top left panel). Nil signal was obtained for blood at TI = 70 ms from left ventricular blood (LV in top right panel), for normal myocardium at TI = 320 ms (arrowheads in lower left panel) and for reperfused infarction at TI = 470 ms (arrows in lower right panel). Regions with faster T1 relaxation, that is, greater Gadolinium concentration, exhibit nil signal at shortest TI setting. Thus, Gadolinium concentration in blood > in normal myocardium > in reperfused infarction at 4 min after administration.
|
|
The accumulation of GdDTPA-albumin in reperfused infarction was fastest when administered immediately before reperfusion ( R1-ratio at 15 min PI: 0.56 ± 0.03). The accumulation was slower when administered at , 1 and 24 h after reperfusion ( R1-ratios at 15 min PI: 0.39 ± 0.03; 0.31 ± 0.04; 0.16 ± 0.01; p < 0.001 compared to administration immediately before reperfusion; one-way ANOVA with post hoc Scheffés test).
The R1-ratio of normal myocardium (0.12 ± 0.01) did not differ among the experimental groups and did not change significantly during the observation period of 1 h after GdDTPA-albumin administration. Reperfused infarction, however, was characterized by increasing R1 ratios after GdDTPA-albumin administration (Fig. 3), reflecting accumulation of the tracer in the injury zone. Accumulation was maximal when GdDTPA-albumin was injected immediately before reperfusion. The accumulation declined as the time of tracer injection was delayed during the reperfusion period (Fig. 3).
Radioisotope data.
The radioactivity ratios in normal and injured myocardium, as measured after 123I-GdDTPA-albumin administration, were similar to the R1-ratios of IR-EPI (Fig. 4). Both MR contrast media and radiotracer accumulated in injured myocardium, but accumulation declined with increasing delay between onset of reperfusion and injection of the tracers (Fig. 4). The distribution of 123I-GdDTPA-albumin in the injury zone was essentially uniform when administered before reperfusion (Fig. 5, A). However, in hearts subjected to delayed tracer administration, 123I-GdDTPA-albumin was distributed in a heterogeneous fashion in the injury zone (Fig. 5, B to D). As the delay increased, less 123I-GdDTPA-albumin was seen in the core of infarction (Fig. 5, D).

View larger version (149K):
[in this window]
[in a new window]
|
Figure 5 Autoradiograms of midventricular slices of hearts subjected to 1 h of coronary occlusion and reperfusion. 123I-GdDTPA-albumin was injected either before reperfusion (A), at (B), at 1 (C) or at 24 h (D) after reperfusion. The accumulation of labeled albumin in the anterolateral wall of the left ventricle indicates vascular injury. Maximal and essentially homogeneous accumulation of labeled albumin occurs when administered before reperfusion (A). When 123I-GdDTPA-albumin was administered later during reperfusion, less indicator was observed in the infarct core (D, arrowheads).
|
|
Regional blood volume.
At onset of reperfusion the apparent blood volume of infarcted myocardium was substantially increased (280% ± 14% of normally perfused myocardium), consistent with hyperemia (Fig. 6). The regional blood volume progressively declined during reperfusion. At h and 1 h there was no significant difference in blood volume between normal and postischemic myocardium (105% ± 11% and 106% ± 16%, respectively). At 24 h after reperfusion the regional blood volume was 69% ± 5% of that of normal myocardium.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 6 Blood volume of ischemically injured myocardium at various durations of reperfusion. Values are expressed as percentage of the blood volume of normal myocardium. The elevated blood volume at onset of reperfusion likely represents postischemic hyperemia; the decreased blood volume after 24 h of reperfusion may be the consequence of edema and external compression of the microvasculature, microvascular plugging and swelling of endothelial cells.
|
|
The R1 ratio of normal myocardium was 0.12 ± 0.01 and did not change significantly during 1 h of observation, which is consistent with a myocardial blood volume of approximately 12 ml/100 g (15,18). This value is similar to previously reported results as measured with various methods (19,20).
Postmortem findings.
The area at risk defined by phthalocyanine blue was 47.1% ± 1.5% of the left ventricular surface area and did not differ significantly among the groups. In MR experiments, the shape and location of infarction on T1-weighted spin echo images was similar to the TTC negative region (Fig. 7). The current model of 1 h of ischemia followed by reperfusion produces substantial myocardial infarction evident as TTC negative area, which is in agreement with previous work (7). All animals subjected to 24-h reperfusion exhibited substantial hemorrhage (Fig. 7). Intramyocardial hemorrhage was less frequent when reflow was 2 h or less.

View larger version (45K):
[in this window]
[in a new window]
|
Figure 7 Different imaging modalities of a heart subjected to 1 h of coronary artery occlusion and 24 h of reperfusion at the same anatomical level: (A) T1-weighted spin echo MRI, (B) IR-EPI, (C) postmortem TTC stain. Four minutes after injection of GdDTPA-albumin, the reperfused infarcted anterolateral wall (arrowheads) is heterogeneously enhanced (A), has a longer T1 value as compared to normal myocardium (B) and is TTC-negative (white) with hemorrhage (dark zone) (C).
|
|
 |
Discussion
|
|---|
The major findings of the current study are 1) accumulation of GdDTPA-albumin as an indicator of ischemic microvascular injury can be quantified by IR-EPI; 2) MR and radioisotope measurements agree; 3) accumulation of GdDTPA-albumin in reperfused infarcted myocardium decreases with duration of reperfusion; 4) distribution of macromolecules in the injury zone is essentially uniform early after reperfusion, but later during reperfusion, GdDTPA-albumin accumulates predominately at the border of the injury zone; 5) reperfusion causes progressive decline of blood volume in reperfused infarction.
Regional blood volume.
Substantial elevation of the blood volume in infarction at onset of reperfusion suggests a hyperemic reaction, which subsided 30 min after reperfusion. Similar findings have been described by other investigators (21,22). During reperfusion the blood volume in the infarct declined progressively. At 24 h after reperfusion the blood volume in the infarct was less than that of normal myocardium, which is consistent with occurrence of the "no reflow" phenomenon as described by Kloner et al. (23,24). The progressive decline of the blood volume in reperfused infarction suggests a progression of the no reflow phenomenon during reperfusion. This finding is consistent with results from Ambrosio et al. (22), who monitored serial changes in regional blood flow in dogs subjected to prolonged reperfusion using radioactive microspheres. These investigators observed progression of the no reflow phenomenon during reperfusion; progressive impairment of flow in postischemic myocardium was associated with capillary plugging (22). Recent contrast-enhanced MR studies confirmed the presence of microvascular obstruction in acutely reperfused infarction in patients (25).
Role of edema, lymphatic clearance and capillary permeability.
Edema associated with elevated tissue pressure evolves in reperfused infarction (26). Elevated tissue pressure may result in compression force on the vasculature, ensuing declining blood volume and aggravating circulation disturbances (27). Edema is promoted by extravasation of macromolecules into the extravascular space and by degradation of the extracellular matrix (28). An elevated tissue pressure can impede the accumulation of macromolecules because transport of large molecules is predominantly driven by motion of bulk fluid (convection), which is governed by pressure gradients (29). Thus, in postischemic myocardium, GdDTPA-albumin would encounter a low transcapillary pressure gradient, and extravasation driven by convective forces would be reduced. Lymphatic clearance in postischemic myocardium is elevated, evidenced as increased flow and protein content of lymphatic fluid in dogs by 53% and 67%, respectively (30). This initial elevation, however, is followed by a gradual decline in lymphatic clearance as reperfusion evolves (31). The route for extravasation of albumin into the extravascular space is likely interendothelial gaps which increase during hypoxia (32) and reoxygenation (4) or reperfusion (33,34).
Regional distribution of labeled albumin.
On autoradiography, an essentially uniform distribution of 123I-GdDTPA-albumin was seen only when the tracer was administered before reperfusion. When administered after reperfusion, there was less labeled albumin in the core of the injury zone than in the periphery. This pattern was more pronounced when the administration of the tracer was delayed after reperfusion. These findings are in agreement with a previous study where hearts were subjected to 1 h of occlusion and 1 h of reperfusion before biotin-labeled GdDTPA-albumin was administered (6). These investigators compared histologic analysis and T1-weighted spin echo images and found dispersion of biotin-GdDTPA-albumin throughout the interstitium and the myocytes; however, less tracer was detectable with either method in the infarct core as opposed to the rim (6). Other investigators studied the effect of various duration of ischemia followed by 2 h of reperfusion before administration of GdDTPA-albumin (7). They described a similar pattern on T1-weighted spin echo MR images ex vivo with a bright border zone and a less enhanced central core which increased in size with increasing (30 to 75 min) duration of ischemia (7).
In vivo assessment of microvascular injury.
In distinction to previous research, the current study employed IR-EPI to measure the accumulation of GdDTPA-albumin in ischemically injured myocardium. Since IR-EPI allows quantitative measurements, it may be used to assess the potential of various new therapeutic agents designed to protect the myocardial vasculature during ischemia and reperfusion. The current study, however, is the first to demonstrate noninvasively in a quantitative fashion that the accumulation of macromolecules in postischemic myocardium declines when the administration is delayed up to 24 h after reperfusion.
Postinfarct alterations of microvascular integrity have recently been shown by Wu et al. (25) in patients using GdDTPA-enhanced MRI. These investigators performed serial measurements after contrast injection and demonstrated that microvascular obstruction, defined as hypoenhancement at 1 to 2 min and hyperenhancement at 5 to 10 min after injection, is predictive of poorer outcome. Other imaging modalities like positron emission tomography (35) and contrast echocardiography (36,37) have been used to assess microvascular injury in reperfused infarction. Myocardial-contrast echocardiography (36) has correlated the presence of contrast defects with poor functional recovery despite restored flow in the infarct-related artery. Unlike MRI, however, this method currently requires intracoronary injection of microbubbles, necessitating cardiac catheterization.
Limitation.
The blood volume estimates in the current study were based on the assumption that GdDTPA-albumin is present only in the intravascular compartment at the moment of injection. Therefore, extrapolation of R1 ratio data back to the moment of injection was assumed to reflect the blood volume. However, severe vascular damage in the injury zone may allow substantial extravasation of GdDTPA-albumin immediately during first pass. Thus, overestimation of the true blood volume may occur.
 |
Footnotes
|
|---|
This study was supported by NIH Grant #T32HL070570-05, and #R01HL52569-01, National Institute of Health, Bethesda, Maryland. Dr. J. Bremerich and Dr. R. Wyttenbach were supported by grants from the Swiss National Science Foundation, Bern, Switzerland. Dr. H. Arheden was supported by the Swedish Heart Lung Foundation, Stockholm, Sweden.
1 All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco. 
 |
References
|
|---|
1. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation. 1980;62:945952[Abstract/Free Full Text]
2. Dauber IM, VanBenthuysen KM, McMurtry IF, et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res. 1990;66:986998[Abstract/Free Full Text]
3. McDonagh PF, Roberts DJ. Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine: Direct observations in isolated rat hearts. Circ Res. 1986;58:127136[Abstract/Free Full Text]
4. Inauen W, Payne DK, Kvietys PR, Granger DN. Hypoxia/reoxygenation increases the permeability of endothelial cell monolayers: role of oxygen radicals. Free Radic Biol Med. 1990;9:219223[CrossRef][Medline]
5. Lim TH, Lee DH, Kim YH, et al. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement. Radiology. 1993;189:765768[Abstract/Free Full Text]
6. Saeed M, van Dijke CF, Mann JS, et al. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast media in reperfused myocardial infarction. J Magn Reson Imaging. 1998;8:616621[Medline]
7. Schwitter J, Saeed M, Wendland MF, et al. Influence of the severity of myocardial injury on the distribution of macromolecules: extra versus intra-vascular Gadolinium-based MR contrast agents. J Am Coll Cardiol. 1997;30:10861094[Abstract]
8. Schmiedl U, Sievers RE, Brasch RC, et al. Acute myocardial ischemia and reperfusion: MR imaging with albumin-Gd-DTPA. Radiology. 1989;170:351356[Abstract/Free Full Text]
9. Wolfe CL, Moseley ME, Wikstrom MG, et al. Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. Circulation. 1989;80:969982[Abstract/Free Full Text]
10. Tweedle MF, Wedeking P, Telser J, et al. Dependence of MR signal intensity on Gd tissue concentration over a broad dose range. Magn Reson Med 1991;22:1914; discussion 1956.
11. Wendland MF, Saeed M, Lauerma K, et al. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn Reson Med. 1997;37:448456[Medline]
12. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med. 1994;32:6676[Medline]
13. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol. 1987;23:665671
14. Hale SL, Kloner RA. Experience from experimental models in the quest to protect myocardium from ischemic damage: update on preconditioning strategies. Curr Opin Cardiol. 1994;9:411416[Medline]
15. Wendland MF, Saeed M, Yu KK, et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med. 1994;32:319329[Medline]
16. Wendland MF, Saeed M, Higgins CB. Strategies for differential enhancement of myocardial ischemia using echoplanar imaging. Invest Radiol. 1991;26(Suppl 1):S236S238 (discussion S245247)
17. Fluck DS, Etherington PJ, OHare D, Winlove CP, Sheridan DJ. Myocardial tissue perfusion determined by particulate and diffusible tracers during ischaemia: what is measured? Cardiovasc Res. 1996;32:869878[CrossRef][Medline]
18. Schmiedl U, Ogan MD, Moseley ME, Brasch RC. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. Am J Roentgenol. 1986;147:12631270[Abstract/Free Full Text]
19. Salisbury PF, Cross CE, Rieben PA. Physiological factors influencing coronary blood volume in isolated dog hearts. Am J Physiol. 1961;200:633636[Abstract/Free Full Text]
20. Judd RM, Levy BI. Effects of barium-induced cardiac contraction on large- and small-vessel intramyocardial blood volume. Circ Res. 1991;68:217225[Abstract/Free Full Text]
21. Crystal GJ, Downey HF, Bashour FA. Small vessel and total coronary blood volume during intracoronary adenosine. Am J Physiol. 1981;241:H194H201[Medline]
22. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:18461861[Abstract/Free Full Text]
23. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:14961508[Medline]
24. Kloner RA, Ganote CE, Jennings RB, Reimer KA. Demonstration of the "no-reflow" phenomenon in the dog heart after temporary ischemia. Recent Adv Stud Cardiac Struct Metab. 1975;10:463474[Medline]
25. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765772[Abstract/Free Full Text]
26. Willerson JT, Scales F, Mukherjee A, et al. Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol. 1977;87:159188[Medline]
27. Vogel WM, Cerel AW, Apstein CS. Post-ischemic cardiac chamber stiffness and coronary vasomotion: the role of edema and effects of dextran. J Mol Cell Cardiol. 1986;18:12071218[CrossRef][Medline]
28. Waldenstrom A, Martinussen HJ, Gerdin B, Hallgren R. Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest. 1991;88:16221628[Medline]
29. Granger HJ, Glen AL, Barnes GE, Lewis RE. Dynamics and control of transmicrovascular fluid exchange. Staub NC, Tayler AET. Edema. New York: Raven Press; 1984. p. 189227
30. Feola M, Glick G. Cardiac lymph flow and composition in acute myocardial ischemia in dogs. Am J Physiol. 1975;229:4448[Abstract/Free Full Text]
31. Ullal SR, Kluge TH, Kerth WJ, Gerbode F. Changes in cardiac lymph of dogs during and after anoxia. Ann Surg. 1972;175:472478[Medline]
32. al-Haboubi HA, Tomlinson DR, Ward BJ. The influence of hypoxia on transvascular leakage in the isolated rat heart: quantitative and ultrastructural studies. J Physiol. 1995;482:157166[Abstract/Free Full Text]
33. McDonagh PF. The role of the coronary microcirculation in myocardial recovery from ischemia. Yale J Biol Med. 1983;56:303311[Medline]
34. Nayler WG, Elz JS. Reperfusion injury: laboratory artifact or clinical dilemma? Circulation. 1986;74:215221[Free Full Text]
35. Jeremy RW, Links JM, Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol. 1990;16:695704[Abstract]
36. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:16991705[Abstract/Free Full Text]
37. Sheil ML, Kaul S, Spotnitz WD. Myocardial contrast echocardiography: development, applications, and future directions. Acad Radiol. 1996;3:260275[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Marques, P. Knaapen, R. Boellaard, N. Westerhof, A. A. Lammertsma, C. A. Visser, and F. C. Visser
Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction
Eur. Heart J.,
October 1, 2007;
28(19):
2320 - 2325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saeed, O. Weber, R. Lee, L. Do, A. Martin, D. Saloner, P. Ursell, P. Robert, C. Corot, and C. B. Higgins
Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging With Intravascular Magnetic Resonance Contrast Media
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
1961 - 1968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Krombach, C. B. Higgins, M. Chujo, and M. Saeed
Gadomer-enhanced MR Imaging in the Detection of Microvascular Obstruction: Alleviation with Nicorandil Therapy
Radiology,
August 1, 2005;
236(2):
510 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Krombach, M. F. Wendland, C. B. Higgins, and M. Saeed
MR Imaging of Spatial Extent of Microvascular Injury in Reperfused Ischemically Injured Rat Myocardium: Value of Blood Pool Ultrasmall Superparamagnetic Particles of Iron Oxide
Radiology,
November 1, 2002;
225(2):
479 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kudo, K. Fukuchi, A. J. Annala, A. F. Chatziioannou, V. Allada, M. Dahlbom, Y.-C. Tai, M. Inubushi, S.-C. Huang, S. R. Cherry, et al.
Noninvasive Measurement of Myocardial Activity Concentrations and Perfusion Defect Sizes in Rats With a New Small-Animal Positron Emission Tomograph
Circulation,
July 2, 2002;
106(1):
118 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rezkalla and R. A. Kloner
No-Reflow Phenomenon
Circulation,
February 5, 2002;
105(5):
656 - 662.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saeed, G. Lund, M. F. Wendland, J. Bremerich, H.-J. Weinmann, and C. B. Higgins
Magnetic Resonance Characterization of the Peri-Infarction Zone of Reperfused Myocardial Infarction With Necrosis-Specific and Extracellular Nonspecific Contrast Media
Circulation,
February 13, 2001;
103(6):
871 - 876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
9 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bonnemeier, F. Hartmann, U. K. H. Wiegand, F. Bode, H. A. Katus, and G. Richardt
Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
44 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Arheden, M. Saeed, C. B. Higgins, D.-W. Gao, P. C. Ursell, J. Bremerich, R. Wyttenbach, M. W. Dae, and M. F. Wendland
Reperfused Rat Myocardium Subjected to Various Durations of Ischemia: Estimation of the Distribution Volume of Contrast Material with Echo-planar MR Imaging
Radiology,
May 1, 2000;
215(2):
520 - 528.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Saeed, J. Bremerich, M. F. Wendland, R. Wyttenbach, H.-J. Weinmann, and C. B. Higgins
Reperfused Myocardial Infarction as Seen with Use of Necrosis-specific versus Standard Extracellular MR Contrast Media in Rats
Radiology,
October 1, 1999;
213(1):
247 - 257.
[Abstract]
[Full Text]
|
 |
|
|